GE Healthcare has launched a new CT scanner targeted at the healthcare market in India that was designed and manufactured in the country.
The company said its Revolution ACT scanner will be marketed in tier II and tier III cities in India and will also be exported to countries in southeast Asia, according to an article in the Business Standard. The system was developed at GE's facility in Bengaluru and will carry a list price 40% lower than that of a comparable scanner imported from outside the country.
GE plans to manufacture about 200 Revolution ACT scanners a year, with a production capacity of 1,000 systems depending on demand, according to the article. The story estimates that there are 3,500 CT scanners installed at hospitals in India.
Sales of Revolution ACT will begin in India as soon as GE receives regulatory approval for the product.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
